BEAM
Price
$22.03
Change
+$0.57 (+2.66%)
Updated
Jul 10 closing price
Capitalization
2.16B
32 days until earnings call
COYA
Price
$6.33
Change
+$0.10 (+1.61%)
Updated
Jul 10 closing price
Capitalization
104.03M
32 days until earnings call
Interact to see
Advertisement

BEAM vs COYA

Header iconBEAM vs COYA Comparison
Open Charts BEAM vs COYABanner chart's image
Beam Therapeutics
Price$22.03
Change+$0.57 (+2.66%)
Volume$3.31M
Capitalization2.16B
Coya Therapeutics
Price$6.33
Change+$0.10 (+1.61%)
Volume$107.55K
Capitalization104.03M
BEAM vs COYA Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. COYA commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and COYA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (BEAM: $22.03 vs. COYA: $6.32)
Brand notoriety: BEAM and COYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 162% vs. COYA: 203%
Market capitalization -- BEAM: $2.16B vs. COYA: $104.03M
BEAM [@Biotechnology] is valued at $2.16B. COYA’s [@Biotechnology] market capitalization is $104.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileCOYA’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • COYA’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and COYA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while COYA’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • COYA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than COYA.

Price Growth

BEAM (@Biotechnology) experienced а +10.09% price change this week, while COYA (@Biotechnology) price change was +6.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

COYA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.16B) has a higher market cap than COYA($104M). COYA YTD gains are higher at: 10.384 vs. BEAM (-11.169). COYA has higher annual earnings (EBITDA): -19.42M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. COYA (35.5M). BEAM has higher revenues than COYA: BEAM (63.6M) vs COYA (3.69M).
BEAMCOYABEAM / COYA
Capitalization2.16B104M2,075%
EBITDA-399.03M-19.42M2,055%
Gain YTD-11.16910.384-108%
P/E RatioN/AN/A-
Revenue63.6M3.69M1,726%
Total Cash1.22B35.5M3,437%
Total Debt158MN/A-
TECHNICAL ANALYSIS
Technical Analysis
BEAMCOYA
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
88%
Declines
ODDS (%)
Bearish Trend 19 days ago
85%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBLGX64.75N/A
N/A
ClearBridge Large Cap Growth A
SEQAX17.34N/A
N/A
NAA World Equity Income A
WIEFX16.08N/A
N/A
Boston Trust Walden International Eq
EMRSX18.77N/A
N/A
JPMorgan Emerging Mkts Rsrch Enh Eq R6
HWSZX75.11N/A
N/A
Hotchkis & Wiley Small Cap Value Z

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+2.66%
CRSP - BEAM
72%
Closely correlated
-1.80%
NTLA - BEAM
65%
Loosely correlated
+0.25%
RXRX - BEAM
64%
Loosely correlated
+2.24%
SYRE - BEAM
58%
Loosely correlated
-3.56%
ABSI - BEAM
58%
Loosely correlated
-3.53%
More

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with KNSA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
+1.69%
KNSA - COYA
40%
Loosely correlated
+0.52%
NTLA - COYA
37%
Loosely correlated
+0.25%
XNCR - COYA
35%
Loosely correlated
-0.54%
SNDX - COYA
34%
Loosely correlated
+6.28%
BEAM - COYA
34%
Loosely correlated
+2.66%
More